HomeComparePFE vs ACN

PFE vs ACN: Dividend Comparison 2026

PFE yields 6.20% · ACN yields 3.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACN wins by $45.28M in total portfolio value
10 years
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →
ACN
ACN
● Live price
3.30%
Share price
$197.55
Annual div
$6.52
5Y div CAGR
85.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.34M
Annual income
$40,254,140.02
Full ACN calculator →

Portfolio growth — PFE vs ACN

📍 ACN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFEACN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFE + ACN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PFE pays
ACN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
ACN
Annual income on $10K today (after 15% tax)
$280.54/yr
After 10yr DRIP, annual income (after tax)
$34,216,019.02/yr
At 15% tax rate, ACN beats the other by $34,192,890.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFE + ACN for your $10,000?

PFE: 50%ACN: 50%
100% ACN50/50100% PFE
Portfolio after 10yr
$22.69M
Annual income
$20,140,675.28/yr
Blended yield
88.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ACN right now

PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
ACN
Analyst Ratings
39
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$299.92
+51.8% upside vs current
Range: $265.00 — $330.00
Altman Z
4.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFE buys
0
ACN buys
0
No recent congressional trades found for PFE or ACN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFEACN
Forward yield6.20%3.30%
Annual dividend / share$1.72$6.52
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.2%85.1%
Portfolio after 10y$51.1K$45.34M
Annual income after 10y$27,210.54$40,254,140.02
Total dividends collected$60.1K$44.91M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$27.50$299.92

Year-by-year: PFE vs ACN ($10,000, DRIP)

YearPFE PortfolioPFE Income/yrACN PortfolioACN Income/yrGap
1← crossover$9,161$701.38$11,311$610.91$2.1KACN
2$8,610$859.79$13,298$1,195.36$4.7KACN
3$8,366$1,081.25$16,660$2,431.14$8.3KACN
4$8,483$1,405.66$23,095$5,268.91$14.6KACN
5$9,084$1,907.24$37,347$12,635.37$28.3KACN
6$10,418$2,732.78$75,308$35,346.62$64.9KACN
7$13,007$4,193.56$203,877$123,297.57$190.9KACN
8$18,010$7,005.87$795,585$577,436.45$777.6KACN
9$28,216$12,979.89$4,749,302$3,898,026.13$4.72MACN
10$51,081$27,210.54$45,335,893$40,254,140.02$45.28MACN

PFE vs ACN: Complete Analysis 2026

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →

ACNTechnology

Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management, intelligent automation comprises robotic process automation, natural language processing, and virtual agents, and liquid application management services, as well as program, project, and service management services; strategy consulting services; critical data elements, data management and governance, data platform and architecture, product-based organization and skills, business adoption, and value realization services; engineering, and research and development digitization; smart connected product design and development; product platform engineering and modernization; product as-a-service enablement; products related to production and operations; autonomous robotics systems; the digital transformation of capital projects; and digital industrial workforce solutions. It also provides data-enabled operating models; technology consulting and artificial intelligence services; services related to talent and organization/human potential; digital commerce; infrastructure services, such as hybrid cloud, network, digital workplace and collaboration, service and experience management, infrastructure as code, and managed edge and IoT devices; cyber defense, applied cybersecurity, managed security, OT security, security strategy and risk, and industry security products; services related to technology innovation; and intelligent automation services. In addition, the company offers cloud, ecosystem, marketing, supply chain management, zero-based budgeting, customer experience, finance consulting, mergers and acquisitions, and sustainability services. Accenture plc was founded in 1951 and is based in Dublin, Ireland.

Full ACN Calculator →
📬

Get this PFE vs ACN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFE vs JNJPFE vs MRKPFE vs ABBVPFE vs BMYPFE vs LLYPFE vs SCHDPFE vs JEPIPFE vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.